NCT01642498View on ClinicalTrials.gov

A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2012

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Hypertension
Interventions
DEVICE

ROX COUPLER

The COUPLER will be used to create an arteriovenous fistula in the iliac region (between the iliac artery and vein).

Trial Locations (18)

9

Beaumont Hospital, Dublin

15

Connolly Hospital, Blanchardstown

1090

ZNA - Cardio Middleheim, Antwerp

Universitair Ziekenhuis Brussel, Brussels

12203

Universitätsmedizin Berlin - Campus Benjamin Franklin, Berlin

35033

Hypertoniezentrum Marburg, Marburg

D-91054

Universitätsklinikum Erlangen, Erlangen

115 27

G. Gennimatas General Hospital of Athens, Athens

Hippokration General Hospital of Athens, Athens

3435CM

St. Antonius Ziekenhuis, Nieuwegein

31 501

Jagiellonian University Collegium Medicum, Krakow

04 628

Institute of Cardiology - Warsaw, Warsaw

BN21 2UD

Eastbourne District General Hospital, Eastbourne

EC1M 6BQ

Queen Mary University of London, London

SW3 6NP

Royal Bromptom, London

SM5 1AA

St. Helier Hospital, Carshalton

CF 14 4XW

University Hospital of Wales, Cardiff

LE3 9QP

University Hospitals of Leicester - Glenfield Hospital, Leicester

All Listed Sponsors
lead

ROX Medical, Inc.

INDUSTRY

NCT01642498 - A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension | Biotech Hunter | Biotech Hunter